14-3-3beta Protein Associates with Insulin Receptor Substrate 1 and Decreases Insulin-stimulated Phosphatidylinositol 3'-Kinase Activity in 3T3L1 Adipocytes*

Atsushi KosakiDagger , Kazunori Yamada, Junko Suga§, Akira Otaka, and Hideshi Kuzuya

From the Clinical Research Unit, Diabetes Center, Kyoto National Hospital, Fushimi-ku, Kyoto 612, Japan, the § Department of Medicine and Clinical Science, Kyoto University Graduate School of Medicine, Sakyo-ku, Kyoto 606, Japan, and the  Faculty of Pharmaceutical Sciences, Kyoto University, Sakyo-ku, Kyoto 606, Japan

    ABSTRACT
Top
Abstract
Introduction
Procedures
Results & Discussion
References

The 14-3-3 protein family has been implicated in growth factor signaling. We investigated whether 14-3-3 protein is involved in insulin signaling in 3T3L1 adipocytes. A significant amount of insulin receptor substrate 1 (IRS-1) was immunodetected in the immunoprecipitate with anti-14-3-3beta antibody at the basal condition. 100 nM insulin increased the amount of IRS-1 in the immunoprecipitate 2.5-fold. The effect of insulin was abolished by 100 nM wortmannin. An in vitro binding study revealed that glutathione S-transferase-14-3-3beta fusion protein directly associates with recombinant IRS-1. Pretreatment of recombinant IRS-1 with alkaline phosphatase clearly decreased this association. Because the recombinant IRS-1 was not phosphorylated on its tyrosine residues, the results suggest that serine/threonine phosphorylation of IRS-1 is responsible for the association. When the cells are treated with insulin, phosphatidylinositol 3'-kinase (PI3K) is supposed to complex either 14-3-3beta -IRS-1 or IRS-1. The 14-3-3beta -IRS-1-PI3K and IRS-1-PI3K complexes were separately prepared by a sequential immunoprecipitation, first with anti-14-3-3beta and then with anti-IRS-1 antibodies. The specific activity of the PI3K in the former was approximately half of that in the latter, suggesting that 14-3-3beta protein bound to IRS-1 inhibits insulin-stimulated lipid kinase activity of PI3K in 3T3L1 adipocytes.

    INTRODUCTION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Insulin promotes the rapid autophosphorylation of its receptor beta -subunits and tyrosine phosphorylation of several cytoplasmic proteins such as Shc, pp60, Gab-1, and insulin receptor substrate (IRS)1 1 and 2. IRS-1 plays a central role in insulin signaling. The protein contains a pleckstrin homology domain, a phosphotyrosine-binding domain that binds to NPXY motif of the insulin receptor beta -subunit and multiple tyrosine residues that are potential phosphorylation sites. The tyrosine-phosphorylated IRS-1 associates with several Src homology 2 domain-containing proteins including Grb-2, SHP-2, Nck, Fyn, and the 85-kDa subunit (p85) of phosphatidylinositol 3'-kinase (PI3K). Associations of these molecules with IRS-1 are believed to further activate downstream signaling systems, including mitogen-activated protein kinase and PI3K cascades, that promote mitogenic and metabolic effects of insulin (for review see Refs. 1 and 2).

14-3-3 protein family, first discovered as acidic proteins in the brain, is highly conserved in animals and plants. At least nine mammalian isoforms have been identified, and six are expressed ubiquitously (3). Originally, 14-3-3 proteins have been shown to be functional as regulators of tryptophan and tyrosine hydroxylases as well as protein kinase C (for review see Ref. 4). However, recently 14-3-3 proteins were found to associate oncogene products, including Raf-1 (5-11), Bcr-Abl, Bcr (12, 13), polyoma middle T antigen (14), and cell cycle control proteins such as Cdc25 phosphatases (15). The interaction of Raf with 14-3-3 leads to Raf activation in several in vivo systems (5, 7, 8). Moreover, the importance of 14-3-3 proteins in signal transduction is suggested by the reports that 14-3-3 protein interacts with PI3K (16) and glycoprotein Ib-IX (17). However, both the mechanism and the physiological role of protein-protein interactions mediated by 14-3-3 proteins are still unclear.

The aim of the present study is to investigate whether the 14-3-3 protein is involved in the insulin signaling pathway. We showed that 14-3-3beta protein directly binds to IRS-1 and that insulin increases this binding via a wortmannin-sensitive pathway in 3T3L1 adipocytes. We also demonstrated that the 14-3-3beta protein negatively regulates insulin-stimulated activity of PI3K.

    EXPERIMENTAL PROCEDURES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

Materials-- Anti-IRS-1 (SC559), anti-phosphotyrosine (SC508), anti-14-3-3beta (SC628), and anti-GST (SC459) antibodies were purchased from Santa Cruz Biotechnology, Inc. (Santa Cruz, CA). Rat recombinant IRS-1 (number 12-128) and anti-p85PI3K antibodies (numbers 05-217 and 06-195) were from Upstate Biotechnology, Inc. (Lake Placid, NY). [gamma -32P]ATP was from New England Nuclear (Wilmington, DE). Oligonucleotides were made by ABI 392 DNA/RNA synthesizer (Foster City, CA). Biosynthetic human insulin was kindly provided by Eli Lilly (Indianapolis, IN). Calf intestine alkaline phosphatase and Pfu DNA polymerase were purchased from Toyobo (Osaka, Japan) and Stratagene (La Jolla, CA), respectively. pGEX-2T vector and glutathione-Sepharose 4B beads were from Pharmacia Biotech Inc. (Uppsala, Sweden). pCRII vector was from Invitrogen (San Diego, CA). 14-3-3beta cDNA was kindly gifted from Dr. Watanabe (Hokkaido University School of Medicine, Sapporo, Japan). Difluorophosphonometyl phenylalanine (difluoroPmp) was kindly gifted from Dr. Burke, Jr (NCI, NIH, Bethesda, MD). Fetal calf serum and cell culture reagents were purchased from Life Technologies, Inc. Donkey anti-rabbit horseradish peroxidase-conjugated antibody and ECL chemiluminescent kit were from Amersham Corp. Other reagents were from Sigma and Attest, Inc. (Kyoto, Japan).

Cell Culture and Preparation-- 3T3L1 cells were purchased from ATCC (Rockville, MD) and were grown and differentiated as described previously (18). After 6 h of serum starvation, cells were stimulated with insulin for 3 min at 37 °C and then immediately frozen with liquid nitrogen. For some experiments, cells were preincubated with 100 nM wortmannin for 20 min. Total cell lysates were prepared by a solubilization in 0.5 ml/10-cm dish of ice-cold lysis buffer (50 mM Hepes, pH 7.5, 10 mM EDTA, 100 mM NaF, 10 mM sodium pyrophosphate, 1% Nonidet P-40, 0.1 mg/ml aprotinin, 2 mM phenylmethylsulfonyl fluoride, 10 µM leupeptin, 2 mM sodium orthovanadate) for 30 min at 4 °C. The insoluble materials were removed by centrifugation (20,000 × g for 20 min at 4 °C). Cytosolic fractions were prepared by a suspending the cells in ice-cold lysis buffer without Nonidet P-40 and homogenizing with a Teflon homogenizer for several strokes. The membrane fractions were removed by ultracentrifugation (100,000 × g for 1 h at 4 °C).

Construction of Fusion Protein-- To prepare GST fusion protein, full-length rat 14-3-3beta cDNA was amplified by polymerase chain reaction using sense primer added to the BamHI site and antisense primer added to the EcoRI site and cloned into pCRII vector. The insertion was restricted with both BamHI and EcoRI and ligated into pGEX-2T vector in-frame. The plasmid was subcloned into DH5alpha cells. Fusion proteins were affinity purified using glutathione-Sepharose 4B beads according to the manufacturer's protocol. The protein is designated GST-14-3-3beta . GST protein alone was also prepared for a negative control.

Peptide Synthesis-- YMXM-containing peptide, YZPZSGSYZPZS (nonphosphorylated form), was synthesized by an Fmoc-based strategy. Norleucines (Z) were used instead of methionines (M) as described previously (19). Boc-based techniques were utilized for the preparation of the phosphopeptide possessing substitution of phosphotyrosine (pY) or difluoroPmp for tyrosine in the two YZPZ motifs (20, 21). The peptides were purified by preparative reverse phase HPLC. Analysis of the purified products by mass spectroscopy and analytical HPLC demonstrated homogeneity and sequence accuracy of the synthesized peptides.

In Vivo Association Study-- 2 mg of total cell lysates were incubated with 2 µg of the antibody indicated for 16 h at 4 °C in an end-over-end mixer, followed by the addition of protein A/G-Sepharose for the last hour. The Sepharose-bound immune complexes were then collected by centrifugation (10,000 × g for 1 min) and washed four times in ice-cold washing buffer (50 mM Hepes, pH 7.5, 150 mM NaCl, 0.1% Nonidet P-40) and once in phosphate-buffered saline. The immune complexes were denatured in Laemmli's sample buffer by boiling for 5 min and then subjected to immunoblotting.

In Vitro Association Study-- To see whether 14-3-3beta protein associates with IRS-1 in vitro, either 2 mg of total cell lysate of 3T3L1 adipocytes or 400 ng of rat recombinant IRS-1 protein was incubated with 50 pmol of either GST alone or GST-14-3-3beta fusion protein in 1.0 ml of lysis buffer for 1 h and then with glutathione-Sepharose 4B beads for another hour at 4 °C. The Sepharose-bound complexes were collected by centrifugation (10,000 × g for 1 min) and washed four times in ice-cold washing buffer and once in phosphate-buffered saline. The complexes were denatured in Laemmli's sample buffer by boiling for 5 min and then subjected to immunoblotting with anti-IRS-1 antibody.

To study whether PI3K associates with 14-3-3beta protein in vitro, 1.5 mg of cytosolic fraction of untreated cells was incubated with 10 µM of YMXM-, pYMXM-, or difluoroPmpMXM-containing peptide for 20 min at 25 °C, and the total mixture was immunoprecipitated with 3 µg of anti-p85 antibody followed by the addition of protein A/G-Sepharose. The immunoprecipitated PI3K was further phosphorylated in vitro in 50 µl of buffer A (20 mM Hepes, pH 7.5, 10 mM MgCl2, 3 mM MnCl2, and 10 µM ATP) for 10 min at 25 °C and then incubated with GST-14-3-3beta fusion protein in 250 µl of lysis buffer for 1 h at 4 °C. The Sepharose-bound immune complexes were collected by centrifugation (10,000 × g for 1 min) and washed four times in ice-cold washing buffer and once in phosphate-buffered saline. The immune complexes were denatured in Laemmli's sample buffer by boiling for 5 min and then subjected to immunoblotting with anti-GST antibody.

Alkaline Phosphatase Treatment-- 400 ng of rat recombinant IRS-1 protein was incubated with 15 units of active or heat-inactivated calf intestine alkaline phosphatase in 20 µl of 50 mM Tris-HCl, pH 8.0, for 30 min at 25 °C and then heat-inactivated for 10 min at 70 °C. The recombinant IRS-1 proteins were then subjected to in vitro association study.

Immunoblotting-- Samples were separated by electrophoresis on 7.5-10% SDS-polyacrylamide gel electrophoresis and transferred to nitrocellulose membranes. The membranes were blocked with 3% bovine serum albumin in TBS (10 mM Tris-HCl, pH 7.5, 150 mM NaCl) and then incubated with the antibody indicated for 3 h at room temperature. The membranes were washed in T-TBS (TBS containing 0.1% Tween-20) for 30 min, incubated with donkey anti-rabbit or anti-mouse horse-radish peroxidase-conjugated antibody in T-TBS for 60 min, and washed for 60 min in T-TBS, and then the proteins were visualized using an ECL chemiluminescent kit. The band densities were quantified using an image analyzer Quantity One System (PDI, Sunnyvale, CA).

PI3K Assay-- PI3K activity was measured as described previously with slight modifications (22, 23). Briefly, the Sepharose-bound immune complexes with the indicated antibody were resuspended in 50 µl of 10 mM Tris-HCl, pH 7.5, 100 mM NaCl, 1 mM EDTA. The reaction was then initiated by the addition of 10 µl of 100 mM MgCl2, 10 µl of 1 mg/ml of phosphatidylinositol, and 10 µl of 100 µM [gamma -32P]ATP (~20 µCi). After 10 min of incubation at 25 °C, the reaction products were analyzed by thin layer chromatography on silica gel plate followed by a BAS-2000 (Fujifilm, Tokyo, Japan) detection. To measure the PI3K activity in Fig. 4, 2 mg of total cell lysate was first immunoprecipitated with 2 µg of anti-14-3-3beta antibody, and then half of the supernatant was immunoprecipitated with 2 µg of anti-IRS-1 antibody. To eliminate the influence of each antibody on the activity of PI3K, 2 µg of anti-IRS-1 and anti-14-3-3beta antibody were added to the first and the second immunoprecipitate, respectively, before the assay.

Statistical Analysis-- Results are expressed as the means ± S.E. All comparisons were made using a two-tailed t test. p < 0.05 was considered statistically significant.

    RESULTS AND DISCUSSION
Top
Abstract
Introduction
Procedures
Results & Discussion
References

To investigate whether 14-3-3beta protein is involved in the insulin signaling pathway, total cell lysates of 3T3L1 adipocytes were immunoprecipitated with anti-14-3-3beta antibody, and the immune complexes were subjected to immunoblots with antibodies against molecules implicated in insulin signaling. We found that a significant amount of IRS-1 was immunodetected in the immunoprecipitate at the basal condition. 100 nM insulin increased 2.5-fold (basal versus insulin-stimulated condition; 5.30 ± 0.41 versus 13.57 ± 1.16 arbitrary units, n = 6, p < 0.01) the amount of IRS-1 in the immunoprecipitate (Fig. 1A, lanes 1 and 2). The increase was detected very rapidly after insulin treatment, reaching to the plateau at 1 min (data not shown). The effect of insulin was abolished when the cells were pretreated with 100 nM wortmannin (Fig. 1A, lane 3). However, wortmannin did not affect the amount of immunoprecipitated IRS-1 at the basal condition (data not shown). To confirm these results, the total cell lysates were immunoprecipitated with anti-IRS-1 antibody, and the immune complexes were subjected to immunoblotting with anti-14-3-3beta antibody (Fig. 1B). Consistent with the former results, 14-3-3beta proteins were immunodetected in the immunoprecipitate at the basal condition. Insulin increased the amount of immunoprecipitated 14-3-3beta proteins. The effect of insulin was reduced by wortmannin pretreatment.


View larger version (38K):
[in this window]
[in a new window]
 
Fig. 1.   Insulin-induced association of 14-3-3beta protein with IRS-1 in 3T3L1 adipocytes. 3T3L1 adipocytes were pretreated with (lanes 3 and 8) or without (lanes 1, 2, 4-7, and 9) 100 nM wortmannin for 20 min at 37 °C. The cells were then treated with (lanes 2, 3, 7, and 8) or without (lanes 1, 4-6, and 9) 100 nM insulin for 3 min at 37 °C. 2 mg of the total cell lysates were immunoprecipitated with anti-14-3-3beta antibody (lanes 1-3 and 9), anti-IRS-1 antibody (lanes 5-8), or control IgG (lane 4). The immunoprecipitates were subjected to immunoblots with anti-IRS-1 (A) or anti-14-3-3beta (B) antibody. Each representative photograph is shown. Blot, immunoblot; alpha -IRS-1, anti-IRS-1 antibody; alpha -14-3-3beta , anti-14-3-3beta antibody; CO, control IgG.

To ensure that 14-3-3beta protein associates with IRS-1, in vitro association experiments were performed using a GST-14-3-3beta fusion protein. GST-14-3-3beta protein was incubated with total cell lysates of 3T3L1 adipocytes treated with or without insulin, followed by glutathione-Sepharose 4B beads precipitation. The precipitates were subjected to immunoblotting using anti-IRS-1 antibody (Fig. 2A). The GST-14-3-3beta protein (but not GST alone) associated with endogenous IRS-1 in the cell lysates at the basal condition. Insulin increased the association by 2-fold. These results are in agreement with the data obtained from in vivo studies (Fig. 1).


View larger version (24K):
[in this window]
[in a new window]
 
Fig. 2.   In vitro association of 14-3-3beta protein with IRS-1. A, 3T3L1 adipocytes were pretreated with (lanes 2 and 4) or without (lanes 1 and 3) 100 nM insulin for 3 min at 37 °C. 2 mg of the total cell lysates were incubated with 50 pmol of GST alone (lanes 1 and 2) or GST-14-3-3beta fusion protein (lanes 3 and 4) for 1 h, followed by the precipitation with glutathione-Sepharose 4B beads for another hour at 4 °C. The precipitates were washed and subjected to an immunoblot with anti-IRS-1 antibody. B, 400 ng of rat recombinant IRS-1 protein were incubated with 50 pmol of either GST alone (lane 6) or GST-14-3-3beta fusion protein (lane 7) in lysis buffer for 1 h and then with glutathione-Sepharose 4B beads for another hour at 4 °C. The precipitates were washed and subjected to an immunoblot with anti-IRS-1 antibody. One-quarter the amount of input recombinant IRS-1 was subjected to the immunoblot as a positive control (lane 5). C, 15 units of either active (lanes 9 and 11) or heat-inactivated (lanes 8 and 10) calf intestine alkaline phosphatase were incubated with 400 ng of rat recombinant IRS-1 protein for 30 min at 25 °C and then heat-inactivated for 10 min at 70 °C. The recombinant IRS-1 proteins were then incubated with 50 pmol of either GST alone (lanes 10 and 11) or GST-14-3-3beta fusion protein (lanes 8 and 9) in lysis buffer for 1 h and then with glutathione-Sepharose 4B beads for another hour at 4 °C. The precipitates were washed and subjected to an immunoblot with anti-IRS-1 antibody. The results show one representative out of three independent experiments. GS4B, glutathione-Sepharose 4B beads; rIRS-1, recombinant IRS-1; ALP, calf intestine alkaline phosphatase; prep., precipitation.

To further address whether the direct association of 14-3-3beta protein with IRS-1 can occur, in vitro reconstitution experiments were performed using recombinant IRS-1 and GST-14-3-3beta fusion protein. We found that the GST-14-3-3beta protein directly associates with recombinant IRS-1 (Fig. 2B). Recently, it has been determined that 14-3-3 protein binds to phosphoserine (pS)-containing motifs by the peptide binding and peptide mapping analysis (24, 25). Therefore, to test whether phophorylated residues of recombinant IRS-1 are involved in the association with 14-3-3beta protein, effects of alkaline phosphatase on the association were determined. Pretreatment of the recombinant IRS-1 with alkaline phosphatase clearly decreased this association (Fig. 2C). The results indicate that 14-3-3beta protein directly binds to IRS-1 via its phosphorylated residues, probably phosphorylated serine/threonine residues, because the recombinant IRS-1 that was used for the experiment was not phosphorylated on tyrosine residues. These in vitro reconstitution experiments could explain the association of 14-3-3beta protein with IRS-1 at the basal condition. However, mechanisms of the insulin-induced increase in the association of 14-3-3beta protein with IRS-1 remains unknown. It was shown that RSXpSXP, RXRXXpS and a cluster of serine residues in the alpha -helix are the binding motifs for 14-3-3 proteins (24-26). Interestingly, IRS-1 contains six RXRXXS motifs (but no RSXSXP motifs) in its amino acid sequence. Four of them are in the phosphotyrosine-binding domain, and the others are located in the region containing the YXXM motifs. Moreover, it was reported that IRS-1 is a substrate for serine kinase of PI3K activated by insulin (27). Taken together with our results, it is tempting to speculate that IRS-1 binds to 14-3-3beta protein via its phosphorylated serine residues such as RXRXXpS motif, and insulin treatment results in the activation of serine kinase of PI3K, which in turn further phosphorylates the serine residues of IRS-1, leading to more association with 14-3-3beta protein. This could be a reason why wortmannin inhibits insulin-induced increase of the IRS-1-14-3-3beta complex (Fig. 1). Of course, other molecules downstream from PI3K, for example, protein kinase B, which is another serine/threonine kinase, may be involved in the insulin-induced increase of the IRS-1-14-3-3beta complex (28). Further study will be necessary to clarify this point.

An alternative possibility is that insulin-stimulated association of 14-3-3beta proteins with IRS-1 is mediated by PI3K. It is well known that tyrosine-phosphorylated IRS-1 upon insulin stimulation associates directly with the p85 subunit of PI3K through pYMXM and pYXXM motifs, resulting in the activation of PI3K (2). It has been reported that insulin induces serine-phosphorylation of p85 by PI3K itself (27, 29). As expected, p85 was detected in the immunoprecipitates with anti-14-3-3beta antibody mainly upon insulin treatment and little in the basal condition. This band was decreased in the presence of wortmannin (Fig. 3A). If 14-3-3beta protein associates with PI3K directly, insulin apparently increases the amount of IRS-1 immunoprecipitated with 14-3-3beta antibody via PI3K. Therefore, to explore this possibility, we activated PI3K in vitro without the insulin receptor-IRS-1 system. pYMXM- or difluoroPmpMXM-containing peptide was incubated with the cytosolic fraction of untreated 3T3L1 adipocytes, and the mixture was immunoprecipitated with anti-p85 antibody (20, 30). The immunoabsorbed PI3K was further phosphorylated by adding ATP and manganese and then subjected to in vitro association experiments with GST-14-3-3beta protein. Although both pYMXM- and difluoroPmpMXM-containing peptide activated the lipid kinase activity of PI3K (Fig. 3B) and also increased phosphorylation of p85 (Fig. 3C), neither pYMXM- nor difluoroPmpMXM-containing peptide increased the association of GST-14-3-3beta protein with PI3K in the absence of IRS-1 molecule (Fig. 3D, upper panel). It is thus unlikely that 14-3-3beta protein directly associates with PI3K in 3T3L1 adipocytes, accounting for the insulin-stimulated increase of IRS-1 in the immunoprecipitates with anti-14-3-3beta antibody. Recently, it was reported that 14-3-3tau protein directly binds to PI3K in human T lymphocytes (16). The difference from our results may be due to the tissue, 14-3-3 isoform, or species specificity. It is of interest to note that human but not mouse p85 of PI3K contains RSXSXP motif in the breakpoint cluster region homologue domain.


View larger version (21K):
[in this window]
[in a new window]
 
Fig. 3.   No association of 14-3-3beta protein with PI3K in the absence of IRS-1. A, 3T3L1 adipocytes were pretreated with (lane 3) or without (lanes 1 and 2) 100 nM wortmannin for 20 min at 37 °C. The cells were then treated with (lanes 2 and 3) or without (lane 1) 100 nM insulin for 3 min at 37 °C. 2 mg of the total cell lysates were immunoprecipitated with anti-14-3-3beta antibody. The immunoprecipitates were subjected to an immunoblot with anti-p85 antibody. The numbers on the right show the positions of 97- and 66-kDa markers. B, 1.5 mg of the cytosol fraction of untreated 3T3L1 adipocytes was incubated with 10 µM of either YMXM- (lane 4), pYMXM- (lane 5), or difluoroPmpMXM-containing (lane 6) peptides for 20 min at 25 °C and immunoprecipitated with anti-p85 antibody. The immunoprecipitated PI3K was subjected to lipid kinase assay, as described under "Experimental Procedures." C, a part of the immunoprecipitated PI3K in B was incubated with 20 µCi of [gamma -32P]ATP in buffer A for 10 min at 25 °C and washed. The samples were subjected to SDS-polyacrylamide gel electrophoresis and autoradiography to visualize the p85 autophosphorylation. D, a part of the immunoprecipitated PI3K in B was further phosphorylated in 50 µl of buffer A for 10 min at 25 °C and then incubated with 30 pmol of GST-14-3-3beta proteins in 200 µl of lysis buffer for 1 h at 4 °C. The immune complexes were washed and subjected to immunoblots with anti-GST (upper panel) or anti-p85 (lower panel) antibody. One-third the amount of input GST-14-3-3beta protein was shown as a positive control (lane 14), and preimmune IgG was used for a negative control (lane 10). The results show one representative out of three independent experiments. alpha -14-3-3beta , anti-14-3-3beta antibody; alpha -p85, anti-p85PI3K antibody; CO, preimmune IgG; Wort, wortmannin; Y, YMXM-peptide; P, pYMXM-peptide; F, difluoroPmpMXM-peptide; PI3P, phosphatidylinositol 3-phosphate.

Because less than half the amount of total IRS-1 associates with 14-3-3beta protein when the cells are treated with insulin (Fig. 1A), PI3K may complex either 14-3-3beta -IRS-1 or IRS-1. To address the physiological significance of the 14-3-3beta -IRS-1-PI3K complex, the 14-3-3beta -IRS-1-PI3K and IRS-1-PI3K complexes were separately prepared by a sequential immunoprecipitation (Fig. 4). The total cell lysates were first immunoprecipitated with anti-14-3-3beta antibody (Fig. 4, lanes 1 and 2), and then half of the supernatant was immunoprecipitated with anti-IRS-1 antibody (Fig. 4, lanes 3 and 4). The lipid kinase activity upon insulin stimulation in the former (14-3-3beta -IRS-1-PI3K complex; Fig. 4A, lane 2) was about 25% of that in the latter (IRS-1-PI3K complex; Fig. 4A, lane 4, and Table I). A part of each sample in Fig. 4A was also subjected to immunoblots with anti-IRS-1 (Fig. 4B), anti-phosphotyrosine (Fig. 4C), anti-p85PI3K (Fig. 4D), or anti-14-3-3beta (Fig. 4E) antibody. After insulin stimulation, the amounts of IRS-1, tyrosine-phosphorylated p185, and p85PI3K in the first immunoprecipitates (Fig. 4, B, C, and D, lanes 2) were about 50% of those in the second immunoprecipitates (Fig. 4, B, C, and D, lanes 4, and Table I). When normalized by the amount of p85, insulin-induced lipid kinase activity was significantly lower in the first immunoprecipitate compared with that in the second immunoprecipitate. Both the tyrosine phosphorylation state of IRS-1 and the association of p85 with IRS-1 were similar in the first and the second immunoprecipitates. Thus 14-3-3beta protein appeared to be a negative regulator for PI3K in insulin signaling system. Here, the question is raised as to how 14-3-3beta protein regulates PI3K. In preliminary studies using immunoblots with anti-p110alpha PI3K antibody, we found that the ratio of p110alpha catalytic subunit to p85 regulatory subunit of PI3K was decreased in the first immunoprecipitate compared with that in the second immunoprecipitate.2 Because the antibody against the p110alpha subunit was low in the affinity, this finding must be further confirmed using different antibodies that work well in the immunoblotting. However, at this point, it should be emphasized that PI3K activity is reduced in the 14-3-3beta -IRS-1-PI3K complex when normalized by the amount of p85 subunit.


View larger version (37K):
[in this window]
[in a new window]
 
Fig. 4.   Lipid kinase activity of PI3K bound to the IRS-1-14-3-3beta complex. 3T3L1 adipocytes were treated with (lane 2) or without (lane 1) 100 nM insulin for 3 min at 37 °C. 2 mg of the total cell lysates were immunoprecipitated with anti-14-3-3beta antibody (alpha -14-3-3beta ), and a half of the supernatant (1/2 Sup.) was then with anti-IRS-1 antibody (alpha -IRS-1) (lanes 3 and 4). The immunoprecipitates were subjected to lipid kinase assay (A). A part of the immunoprecipitate in A was immunoblotted with anti-IRS-1 (B), anti-phosphotyrosine (C), anti-p85PI3K (D), or anti-14-3-3beta (E) antibody. Representative photographs are shown. PI3P, phosphatidylinositol 3-phosphate.

                              
View this table:
[in this window]
[in a new window]
 
Table I
Lipid kinase activity of PI3K bound to the IRS-1-14-3-3beta complex
The band densities of immunoblots and lipid kinase activity in Fig. 4 (lanes 2 and 4) were quantified. Results are expressed as the percentages of the values of the second IP for lipid kinase, IRS-1, pTyr, and p85 and as the percentages of the value of the first IP for 14-3-3beta . Data are the means ± S.E. of three or four experiments.

The physiological role of protein-protein interactions mediated by 14-3-3 proteins is still under investigations. Recently, 14-3-3 protein has been shown to be a modulator of kinases including Raf-1, protein kinase C, and PI3K (4, 16). Furthermore, an importance of 14-3-3 protein as a chaperone as well as an adapter molecule has recently been proposed (31). Indeed, it was reported that 14-3-3 protein mediates the interaction of Bcr and Raf and the interaction of A20 protein and c-Raf by functioning as a bridging adapter molecule (13, 32). Therefore, we tested whether 14-3-3beta protein is acting as an adapter molecule in between IRS-1 and Raf-1. Total cell lysates of 3T3L1 adipocytes treated with or without insulin were immunoprecipitated with anti-IRS-1 antibody, and the immune complexes were subjected to immunoblotting with anti-Raf-1 antibody. However, the results did not support the presence of interaction between IRS-1 and Raf-1 via 14-3-3beta protein in the 3T3L1 adipocytes, despite the fact that the interaction between 14-3-3beta and Raf-1 protein was clearly observed.2 In conclusion, in this study we showed that the 14-3-3 protein is another molecule bound to IRS-1 that modulates PI3K in insulin signaling system in 3T3L1 adipocytes.

    ACKNOWLEDGEMENTS

We thank Dr. Masahiko Watanabe for a gift of 14-3-3beta cDNA, Dr. Terrence R. Burke, Jr. for a gift of difluorophosphonometyl phenylalanine, and the Radioisotope Research Center of Kyoto University (Kyoto, Japan) for helpful support. We also thank Michiyo Amaoka and Yumi Tanaka for technical assistance and Kuniko Fukami for secretarial assistance.

    FOOTNOTES

* The costs of publication of this article were defrayed in part by the payment of page charges. The article must therefore be hereby marked "advertisement" in accordance with 18 U.S.C. Section 1734 solely to indicate this fact.

Dagger To whom correspondence should be addressed: Clinical Research Unit, Diabetes Center, Kyoto National Hospital, 1-1 Fukakusa-Mukaihata, Fushimi-ku, Kyoto 612, Japan. Tel.: 81-75-641-9161, Ext. 528; Fax: 81-75-645-2781; E-mail: akosaki{at}osk2.3web.ne.jp.

1 The abbreviations used are: IRS, insulin receptor substrate; PI3K, phosphatidylinositol 3'-kinase; GST, glutathione S-transferase; IP, immunoprecipitation; difluoroPmp, difluorophosphonometyl phenylalanine; Fmoc, N-(9-fluorenyl)methoxycarbonyl; HPLC, high pressure liquid chromatography; TBS, Tris-buffered saline.

2 A. Kosaki, K. Yamada, and H. Kuzuya, unpublished observation.

    REFERENCES
Top
Abstract
Introduction
Procedures
Results & Discussion
References

  1. Cheatham, B., and Kahn, C. R. (1995) Endocr. Rev. 16, 117-142[Medline] [Order article via Infotrieve]
  2. Myers, M. G., Jr., and White, M. F. (1995) Trends Endocrinol. Metab. 6, 209-215[CrossRef]
  3. Watanabe, M., Isobe, T., Ichimura, T., Kuwano, R., Takahashi, Y., Kondo, H., and Inoue, Y. (1994) Mol. Brain Res. 25, 113-121 [Medline] [Order article via Infotrieve]
  4. Aitken, A. (1995) Trends Biochem. Sci. 20, 95-97[CrossRef][Medline] [Order article via Infotrieve]
  5. Fantl, W. J., Muslin, A. J., Kikuchi, A., Martin, J. A., MacNicol, A. M., Gross, R. W., Williams, L. T. (1994) Nature 371, 612-614[CrossRef][Medline] [Order article via Infotrieve]
  6. Fu, H., Xia, K., Pallas, D. C., Cui, C., Conroy, K., Narsimhan, R. P., Mamon, H., Collier, R. J., Roberts, T. M. (1994) Science 266, 126-129[Medline] [Order article via Infotrieve]
  7. Freed, E., Symons, M., Macdonald, S. G., McCormick, F., Ruggieri, R. (1994) Science 265, 1713-1716[Medline] [Order article via Infotrieve]
  8. Irie, K., Gotoh, Y., Yashar, B. M., Errede, B., Nishida, E., Matsumoto, K. (1994) Science 265, 1716-1719[Medline] [Order article via Infotrieve]
  9. Yamamori, B., Kuroda, S., Shimizu, K., Fukui, K., Ohtsuka, T., and Takai, Y. (1995) J. Biol. Chem. 270, 11723-11726[Abstract/Free Full Text]
  10. Li, S., Janosch, P., Tanji, M., Rosenfeld, G. C., Waymire, J. C., Mischak, H., Kolch, W., Sedivy, J. M. (1995) EMBO J. 14, 685-696[Abstract]
  11. Michaud, N. R., Fabian, J. R., Mathes, K. D., Morrison, D. K. (1995) Mol. Cell. Biol. 15, 3390-3397[Abstract]
  12. Reuther, G. W., Fu, H., Cripe, L. D., Collier, R. J., Pendergast, A. M. (1994) Science 266, 129-133[Medline] [Order article via Infotrieve]
  13. Braselmann, S., and McCormick, F. (1995) EMBO J. 14, 4839-4848[Abstract]
  14. Pallas, D. C., Fu, H., Haehnel, L. C., Weller, W., Collier, R. J., Roberts, T. M. (1994) Science 265, 535-537[Medline] [Order article via Infotrieve]
  15. Conklin, D. S., Galaktionov, K., and Beach, D. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 7892-7896[Abstract]
  16. Bonnefoy-Berard, N., Liu, Y., von Willebrand, M., Sung, A., Elly, C., Mustelin, T., Yoshida, H., Ishizaka, K., Altman, A. (1995) Proc. Natl. Acad. Sci. U. S. A. 92, 10142-10146[Abstract]
  17. Du, X., Harris, S. J., Tetaz, T. J., Ginsberg, M. H., Berndt, M. C. (1994) J. Biol. Chem. 269, 18287-18290[Abstract/Free Full Text]
  18. Kosaki, A., Yamada, K., and Kuzuya, H. (1996) Diabetes 45, 1744-1749[Abstract]
  19. Herbst, J. J., Andrews, G., Contillo, L., Lamphere, L., Gardner, J., Lienhard, G. E., Gibbs, E. M. (1994) Biochemistry 33, 9376-9381[Medline] [Order article via Infotrieve]
  20. Otaka, A., Miyoshi, K., Kaneko, M., Tamamura, H., Fujii, N., Nomizu, M., Burke, T. R., Jr., Roller, P. P. (1995) J. Org. Chem. 60, 3967-3974
  21. Burke, T. R., Jr., Smyth, M. S., Otaka, A., Roller, P. P. (1993) Tetrahedron Lett. 34, 4125-4128[CrossRef]
  22. Suga, J., Yoshimasa, Y., Yamada, K., Yamamoto, Y., Inoue, G., Okamoto, M., Hayashi, T., Shigemoto, M., Kosaki, A., Kuzuya, H., and Nakao, K. (1997) Diabetes 46, 735-741[Abstract]
  23. Lamphere, L., Carpenter, C. L., Sheng, Z., Kallen, R. G., and Lienhard, G. E. (1994) Am. J. Physiol. E486-E494
  24. Muslin, A. J., Tanner, J. W., Allen, P. M., Shaw, A. S. (1996) Cell 84, 889-897[Medline] [Order article via Infotrieve]
  25. Zha, J., Harada, H., Yang, E., Jockel, J., and Korsmeyer, S. J. (1996) Cell 87, 619-628[Medline] [Order article via Infotrieve]
  26. Du, X., Fox, J. E., and Pei, S. (1996) J. Biol. Chem. 271, 7362-7367[Abstract/Free Full Text]
  27. Lam, K., Carpenter, C. L., Ruderman, N. B., Friel, J. C., Kelly, K. L. (1994) J. Biol. Chem. 269, 20648-20652[Abstract/Free Full Text]
  28. Burgering, B. M. T., and Coffer, P. J. (1995) Nature 376, 599-602[CrossRef][Medline] [Order article via Infotrieve]
  29. Dhand, R., Hiles, I., Panayotou, G., Roche, S., Fry, J. M., Gout, I., Totty, N. F., Truong, O., Vicendo, P., Yonezawa, K., Kasuga, M., Courtneidge, S. A., Waterfield, M. D. (1994) EMBO J. 13, 522-533[Abstract]
  30. Herbst, J. J., Andrews, G. C., Contillo, L. G., Singleton, D. H., Genereux, P. E., Gibbs, E. M., Lienhard, G. E. (1995) J. Biol. Chem. 270, 26000-26005[Abstract/Free Full Text]
  31. Jones, D. H., Ley, S., and Aitken, A. (1995) FEBS Lett. 368, 55-58[CrossRef][Medline] [Order article via Infotrieve]
  32. Vincenz, C., and Dixit, V. M. (1996) J. Biol. Chem. 271, 20029-20034[Abstract/Free Full Text]


Copyright © 1998 by The American Society for Biochemistry and Molecular Biology, Inc.